{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gnidia sericocephala", "HIV", "HIV in PBMC", "antiretroviral therapy", "daphnane-type compounds", "protein kinase C activation", "reverse HIV latency"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35891417", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["1437", "10.3390/v14071437"], "Journal": {"ISSN": "1999-4915", "JournalIssue": {"Volume": "14", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "30"}}, "Title": "Viruses", "ISOAbbreviation": "Viruses"}, "ArticleTitle": "HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant <i>Gnidia sericocephala</i> (<i>Thymelaeaceae</i>).", "Abstract": {"AbstractText": ["Despite the success of combination antiretroviral therapy (cART), HIV persists in low- and middle-income countries (LMIC) due to emerging drug resistance and insufficient drug accessibility. Furthermore, cART does not target latently-infected CD4+ T cells, which represent a major barrier to HIV eradication. The \u201cshock and kill\u201d therapeutic approach aims to reactivate provirus expression in latently-infected cells in the presence of cART and target virus-expressing cells for elimination. An attractive therapeutic prototype in LMICs would therefore be capable of simultaneously inhibiting viral replication and inducing latency reversal. Here we report that Gnidia sericocephala, which is used by traditional health practitioners in South Africa for HIV/AIDS management to supplement cART, contains at least four daphnane-type compounds (yuanhuacine A (1), yuanhuacine as part of a mixture (2), yuanhuajine (3), and gniditrin (4)) that inhibit viral replication and/or reverse HIV latency. For example, 1 and 2 inhibit HIV replication in peripheral blood mononuclear cells (PBMC) by >80% at 0.08 \u00b5g/mL, while 1 further inhibits a subtype C virus in PBMC with a half-maximal effective concentration (EC50) of 0.03 \u00b5M without cytotoxicity. Both 1 and 2 also reverse HIV latency in vitro consistent with protein kinase C activation but at 16.7-fold lower concentrations than the control prostratin. Both 1 and 2 also reverse latency in primary CD4+ T cells from cART-suppressed donors with HIV similar to prostratin but at 6.7-fold lower concentrations. These results highlight G. sericocephala and components 1 and 2 as anti-HIV agents for improving cART efficacy and supporting HIV cure efforts in resource-limited regions."]}, "AuthorList": [{"Identifier": ["0000-0001-7126-3447"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria 0028, South Africa."}], "LastName": "Tembeni", "ForeName": "Babalwa", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Sciorillo", "ForeName": "Amanda", "Initials": "A"}, {"Identifier": ["0000-0003-1095-365X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria 0028, South Africa."}], "LastName": "Invernizzi", "ForeName": "Luke", "Initials": "L"}, {"Identifier": ["0000-0003-4945-6511"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Virology, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland."}], "LastName": "Klimkait", "ForeName": "Thomas", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Virology, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland."}], "LastName": "Urda", "ForeName": "Lorena", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria 0028, South Africa."}], "LastName": "Moyo", "ForeName": "Phanankosi", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria 0028, South Africa."}, {"Identifier": [], "Affiliation": "Agricultural Research Council-Vegetables, Industrial and Medicinal Plants, Private Bag X293, Pretoria 0001, South Africa."}], "LastName": "Naidoo-Maharaj", "ForeName": "Dashnie", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Levitties", "ForeName": "Nathan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Gyampoh", "ForeName": "Kwasi", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Zu", "ForeName": "Guorui", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Yuan", "ForeName": "Zhe", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jonathan Lax Immune Disorders Treatment Center, Philadelphia Fight Community Health Centers, Philadelphia, PA 19107, USA."}], "LastName": "Mounzer", "ForeName": "Karam", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ungangezulu Indigenous Remedies, J Uitval, Wasbank 2920, South Africa."}], "LastName": "Nkabinde", "ForeName": "Siphathimandla", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ungangezulu Indigenous Remedies, J Uitval, Wasbank 2920, South Africa."}], "LastName": "Nkabinde", "ForeName": "Magugu", "Initials": "M"}, {"Identifier": ["0000-0003-1946-3120"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Africa Health Research Institute, Congella 4013, South Africa."}, {"Identifier": [], "Affiliation": "Discipline of Traditional Medicine, University of KwaZulu-Natal, Durban 4001, South Africa."}, {"Identifier": [], "Affiliation": "Faculty of Health Sciences, Durban University of Technology, Durban 4001, South Africa."}], "LastName": "Gqaleni", "ForeName": "Nceba", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Tietjen", "ForeName": "Ian", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA 19104, USA."}], "LastName": "Montaner", "ForeName": "Luis J", "Initials": "LJ"}, {"Identifier": ["0000-0002-6512-304X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria 0028, South Africa."}], "LastName": "Maharaj", "ForeName": "Vinesh", "Initials": "V"}], "GrantList": [{"GrantID": "UM1 AI126620", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "107752/Z/15/Z", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "UM1AI126620 and UM1AI64570", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}, {"GrantID": "P30 AI 045880", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}, {"GrantID": "CIHR PJT-153057", "Agency": "CIHR", "Country": "Canada"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Viruses", "NlmUniqueID": "101509722", "ISSNLinking": "1999-4915"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}, {"RegistryNumber": "34807-41-5", "NameOfSubstance": "mezerein"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "CD4-Positive T-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Diterpenes"}, {"QualifierName": [], "DescriptorName": "HIV Infections"}, {"QualifierName": ["physiology"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Leukocytes, Mononuclear"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Thymelaeaceae"}, {"QualifierName": [], "DescriptorName": "Virus Activation"}, {"QualifierName": [], "DescriptorName": "Virus Latency"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "UNAIDS  Global AIDS update: Seizing the Moment: Tackling Entrenched Inequalities to End Epidemics. Geneva 2020.  [(accessed on 27 June 2022)].  Available online:  https://healtheducationresources.unesco.org/library/documents/global-aids-update-2020-seizing-moment-tackling-entrenched-inequalities-end#:~:text=to%20end%20epidemics-Global%20AIDS%20update%202020%3A%20seizing%20the%20moment%3A%20tackling,entrenched%20inequalities%20to%20end%20epidemics&text=380%20p.&text=UNAIDS%20report%20on%20the%20global,HIV%20progress%20way%20off%20course."}, {"Citation": "Omolo J.J., Maharaj V., Naidoo D., Klimkait T., Malebo H.M., Mtullu S., Lyaruu H.V.M., de Koning C.B. Bioassay-Guided Investigation of the Tanzanian Plant Pyrenacantha kaurabassana for Potential Anti-HIV-Active Compounds. J. Nat. Prod. 2012;75:1712\u20131716. doi: 10.1021/np300255r.", "ArticleIdList": ["10.1021/np300255r", "23002902"]}, {"Citation": "Ngo-Giang-Huong N., Huynh T.H.K., Dagnra A.Y., Toni T.-D., I Maiga A., Kania D., Eymard-Duvernay S., Peeters M., Soulie C., Peytavin G., et al. Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries. J. Antimicrob. Chemother. 2018;74:462\u2013467. doi: 10.1093/jac/dky443.", "ArticleIdList": ["10.1093/jac/dky443", "PMC6337899", "30418575"]}, {"Citation": "Chimukangara B., Kharsany A.B., Lessells R.J., Naidoo K., Rhee S.-Y., Manasa J., Gr\u00e4f T., Lewis L., Cawood C., Khanyile D., et al. Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa. AIDS Res. Hum. Retrovir. 2019;35:129\u2013138. doi: 10.1089/aid.2018.0202.", "ArticleIdList": ["10.1089/aid.2018.0202", "PMC6360398", "30430843"]}, {"Citation": "Moyo S., Hunt G., Zuma K., Zungu M., Marinda E., Mabaso M., Kana V., Kalimashe M., Ledwaba J., Naidoo I., et al. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey. PLoS ONE. 2020;15:e0241071. doi: 10.1371/journal.pone.0241071.", "ArticleIdList": ["10.1371/journal.pone.0241071", "PMC7641411", "33147285"]}, {"Citation": "UNAIDS  UNAIDS Data 2021. Geneva.  [(accessed on 12 May 2022)].  Available online:  https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2021/july/20210714_global-aids-update_en.pdf/"}, {"Citation": "Cillo A.R., Sobolewski M.D., Bosch R.J., Fyne E., Piatak M., Coffin J.M., Mellors J.W. Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. USA. 2014;111:7078\u20137083. doi: 10.1073/pnas.1402873111.", "ArticleIdList": ["10.1073/pnas.1402873111", "PMC4024870", "24706775"]}, {"Citation": "Ventura J.D. Human immunodeficiency virus 1 (HIV-1): Viral latency, the reservoir, and the cure. Yale J. Biol. Med. 2020;93:549\u2013560.", "ArticleIdList": ["PMC7513431", "33005119"]}, {"Citation": "Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., Quinn T.C., Chadwick K., Margolick J., Brookmeyer R., et al. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy. Science. 1997;278:1295\u20131300. doi: 10.1126/science.278.5341.1295.", "ArticleIdList": ["10.1126/science.278.5341.1295", "9360927"]}, {"Citation": "Hashemi P., Sadowski I. Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens. Med. Res. Rev. 2019;40:881\u2013908. doi: 10.1002/med.21638.", "ArticleIdList": ["10.1002/med.21638", "PMC7216841", "31608481"]}, {"Citation": "Archin N.M., Liberty A.L., Kashuba A.D., Choudhary S.K., Kuruc J.D., Crooks A.M., Parker D.C., Anderson E.M., Kearney M., Strain M.C., et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487:482\u2013485. doi: 10.1038/nature11286.", "ArticleIdList": ["10.1038/nature11286", "PMC3704185", "22837004"]}, {"Citation": "Abner E., Jordan A. HIV \u201cshock and kill\u201d therapy: In need of revision. Antivir. Res. 2019;166:19\u201334. doi: 10.1016/j.antiviral.2019.03.008.", "ArticleIdList": ["10.1016/j.antiviral.2019.03.008", "30914265"]}, {"Citation": "Boucau J., Das J., Joshi N., Le Gall S. Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells. PLOS Pathog. 2020;16:e1008442. doi: 10.1371/journal.ppat.1008442.", "ArticleIdList": ["10.1371/journal.ppat.1008442", "PMC7112239", "32196533"]}, {"Citation": "Andersen R.J., Ntie-Kang F., Tietjen I. Natural product-derived compounds in HIV suppression, remission, and eradication strategies. Antivir. Res. 2018;158:63\u201377. doi: 10.1016/j.antiviral.2018.07.016.", "ArticleIdList": ["10.1016/j.antiviral.2018.07.016", "30063970"]}, {"Citation": "Chan C.N., McMonagle E.L., Hosie M.J., Willett B.J. Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells. Virus Res. 2013;171:121\u2013128. doi: 10.1016/j.virusres.2012.11.004.", "ArticleIdList": ["10.1016/j.virusres.2012.11.004", "PMC3566544", "23201205"]}, {"Citation": "Mehla R., Bivalkar-Mehla S., Zhang R., Handy I., Albrecht H., Giri S., Nagarkatti P., Nagarkatti M., Chauhan A. Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner. PLoS ONE. 2010;5:e11160. doi: 10.1371/journal.pone.0011160.", "ArticleIdList": ["10.1371/journal.pone.0011160", "PMC2886842", "20585398"]}, {"Citation": "Vidal V., Potterat O., Louvel S., Hamy F., Mojarrab M., Sanglier J.-J., Klimkait T., Hamburger M. Library-Based Discovery and Characterization of Daphnane Diterpenes as Potent and Selective HIV Inhibitors in Daphne gnidium. J. Nat. Prod. 2011;75:414\u2013419. doi: 10.1021/np200855d.", "ArticleIdList": ["10.1021/np200855d", "22148316"]}, {"Citation": "Pierens G.K. 1H and 13C NMR scaling factors for the calculation of chemical shifts in commonly used solvents using density functional theory. J. Comput. Chem. 2014;35:1388\u20131394. doi: 10.1002/jcc.23638.", "ArticleIdList": ["10.1002/jcc.23638", "24854878"]}, {"Citation": "Lanier E.R., Ptak R.G., Lampert B.M., Keilholz L., Hartman T., Buckheit R.W., Mankowski M.K., Osterling M.C., Almond M.R., Painter G.R. Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIV. Antimicrob. Agents Chemother. 2010;54:2901\u20132909. doi: 10.1128/AAC.00068-10.", "ArticleIdList": ["10.1128/AAC.00068-10", "PMC2897300", "20439609"]}, {"Citation": "Ptak R.G., Gallay P.A., Jochmans D., Halestrap A.P., Ruegg U.T., Pallansch L.A., Bobardt M.D., de B\u00e9thune M.-P., Neyts J., De Clercq E., et al. Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent. Antimicrob. Agents Chemother. 2008;52:1302\u20131317. doi: 10.1128/AAC.01324-07.", "ArticleIdList": ["10.1128/AAC.01324-07", "PMC2292519", "18212100"]}, {"Citation": "Jordan A., Bisgrove D., Verdin E. J Lat 10-6-HIV-repsoducibly establishes a latent infection after acute infection of T cells in vitro-cdg188. EMBO J. 2003;22:1868\u20131877. doi: 10.1093/emboj/cdg188.", "ArticleIdList": ["10.1093/emboj/cdg188", "PMC154479", "12682019"]}, {"Citation": "Schonhofer C., Yi J., Sciorillo A., Andrae-Marobela K., Cochrane A., Harris M., Brumme Z.L., Brockman M.A., Mounzer K., Hart C., et al. Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency. Biochem. Pharmacol. 2021;186:114462. doi: 10.1016/j.bcp.2021.114462.", "ArticleIdList": ["10.1016/j.bcp.2021.114462", "PMC8052299", "33577894"]}, {"Citation": "Yuan Z., Wang N., Kang G., Niu W., Li Q., Guo J. Controlling Multicycle Replication of Live-Attenuated HIV-1 Using an Unnatural Genetic Switch. ACS Synth. Biol. 2017;6:721\u2013731. doi: 10.1021/acssynbio.6b00373.", "ArticleIdList": ["10.1021/acssynbio.6b00373", "PMC5400733", "28106981"]}, {"Citation": "Adachi A., E Gendelman H., Koenig S., Folks T., Willey R., Rabson A., A Martin M. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 1986;59:284\u2013291. doi: 10.1128/jvi.59.2.284-291.1986.", "ArticleIdList": ["10.1128/jvi.59.2.284-291.1986", "PMC253077", "3016298"]}, {"Citation": "Hou Z.-L., Yao G.-D., Song S.-J. Daphnane-type diterpenes from genus Daphne and their anti-tumor activity. Chin. Herb. Med. 2021;13:145\u2013156. doi: 10.1016/j.chmed.2020.09.006.", "ArticleIdList": ["10.1016/j.chmed.2020.09.006"]}, {"Citation": "De Mieri M., Du K., Neuburger M., Saxena P., Zietsman P.C., Hering S., van der Westhuizen J.H., Hamburger M. hERG Channel Inhibitory Daphnane Diterpenoid Orthoesters and Polycephalones A and B with Unprecedented Skeletons from Gnidia polycephala. J. Nat. Prod. 2015;78:1697\u20131707. doi: 10.1021/acs.jnatprod.5b00344.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00344", "26091146"]}, {"Citation": "Zhang S., Li X., Zhang F., Yang P., Gao X., Song Q. Preparation of yuanhuacine and relative daphne diterpene esters from Daphne genkwa and structure\u2014Activity relationship of potent inhibitory activity against DNA topoisomerase I. Bioorganic Med. Chem. 2006;14:3888\u20133895. doi: 10.1016/j.bmc.2006.01.055.", "ArticleIdList": ["10.1016/j.bmc.2006.01.055", "16488610"]}, {"Citation": "G\u00f6rick C., Melzig M.F. Gniditrin is the main diterpenoid constituent in the bark of Daphne mezereum L. Die Pharm. 2013;68:640\u2013642. doi: 10.1692/ph.2013.6522.", "ArticleIdList": ["10.1692/ph.2013.6522", "23923651"]}, {"Citation": "Emert J., Breslow R. Gnididin, gniditrin, and gnidicin, novel potent antileukemic diterpenoid esters from Gnidia lamprantha. J. Am. Chem. Soc. 1975;97:672\u2013673.", "ArticleIdList": ["1133369"]}, {"Citation": "Jin Y.-X., Shi L.-L., Zhang D.-P., Wei H.-Y., Si Y., Ma G.-X., Zhang J. A Review on Daphnane-Type Diterpenoids and Their Bioactive Studies. Molecules. 2019;24:1842. doi: 10.3390/molecules24091842.", "ArticleIdList": ["10.3390/molecules24091842", "PMC6540581", "31086098"]}, {"Citation": "Liao S.-G., Chen H.-D., Yue J.-M. Plant Orthoesters. Chem. Rev. 2009;109:1092\u20131140. doi: 10.1021/cr0782832.", "ArticleIdList": ["10.1021/cr0782832", "19182998"]}, {"Citation": "Wang M., Tietjen I., Chen M., Williams D.E., Daoust J., Brockman M.A., Andersen R.J. Sesterterpenoids Isolated from the Sponge Phorbas sp. Activate Latent HIV-1 Provirus Expression. J. Org. Chem. 2016;81:11324\u201311334. doi: 10.1021/acs.joc.6b02312.", "ArticleIdList": ["10.1021/acs.joc.6b02312", "27768313"]}, {"Citation": "Shawon J., Akter Z., Hossen M.M., Akter Y., Sayeed A., Junaid M., Afrose S.S., Khan M.A. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism. Curr. Pharm. Des. 2020;26:5241\u20135260. doi: 10.2174/1381612826666201106093912.", "ArticleIdList": ["10.2174/1381612826666201106093912", "33155902"]}, {"Citation": "Lai W., Huang L., Zhu L., Ferrari G., Chan C., Li W., Lee K.-H., Chen C.-H. Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C \u03b2. J. Med. Chem. 2015;58:8638\u20138646. doi: 10.1021/acs.jmedchem.5b01233.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01233", "PMC4767159", "26509731"]}, {"Citation": "Otsuki K., Li W., Miura K., Asada Y., Huang L., Chen C.-H., Lee K.-H., Koike K. Isolation, Structural Elucidation, and Anti-HIV Activity of Daphnane Diterpenoids from Daphne odora. J. Nat. Prod. 2020;83:3270\u20133277. doi: 10.1021/acs.jnatprod.0c00540.", "ArticleIdList": ["10.1021/acs.jnatprod.0c00540", "PMC8176625", "32997496"]}, {"Citation": "Huang L., Ho P., Yu J., Zhu L., Lee K.-H., Chen C.-H. Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1. PLoS ONE. 2011;6:e26677. doi: 10.1371/journal.pone.0026677.", "ArticleIdList": ["10.1371/journal.pone.0026677", "PMC3200356", "22039528"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "23"}, {"Year": "2022", "Month": "6", "Day": "21"}, {"Year": "2022", "Month": "6", "Day": "24"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "1", "Minute": "44"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35891417", "PMC9318819", "10.3390/v14071437", "v14071437"]}}], "PubmedBookArticle": []}